Peptide Synthesis Service Market projected to reach USD 924 Million by 2030, growing at a CAGR of 7.7% during the forecast period of 2023-2030 – pronounced by MarketDigits in its recent study
The Global Peptide Synthesis Service Market was valued USD 550 Million in 2023 and projected to reach USD 924 Million by 2030, growing at a CAGR of 7.7% during the forecast period of 2023-2030
Richmond, Dec. 06, 2023 (GLOBE NEWSWIRE) — According to a research report “Peptide Synthesis Service Market”, by Purity levels (Under 75%, 75% to 95%, Above 95%), Technology (Solid-phase peptide Synthesis, Solution-phase Peptide Synthesis, Hybrid & Recombinant Technology), End Use (Pharmaceuticals & Biotechnology Companies, CDMOs & CROs, Academics & Research Institutes), and Region – Global Forecast to 2030.
Global Peptide Synthesis Service Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 550 Million |
| Market size value in 2030 | USD 924 Million |
| CAGR (2023-2030) | 7.7% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Purity levels, Technology, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
|
|
|
|
| Sample of Companies Covered |
|
|
|
|
Download the Sample – https://www.marketdigits.com/request/sample/3709
TOC Covers in Depth & Breath on Peptide Synthesis Service Market
170 – Market Data Tables
65 – List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
Peptide synthesis service, a rapidly evolving field in the realm of cybersecurity and data protection, is poised to make a significant impact in the technology sector. It is a cutting-edge approach that ensures data remains confidential and secure, even when processed in untrusted environments. As organizations grapple with increasingly complex and sophisticated threats to their sensitive information, the Peptide Synthesis Service market has seen substantial growth and innovation. Peptide Synthesis Service is an emerging technology that is designed to protect sensitive data while it is being processed by applications in the cloud or other computing environments. It aims to keep data encrypted and secure even during processing, thereby minimizing the risk of data breaches and unauthorized access. The Peptide Synthesis Service market has been growing as organizations increasingly recognize the importance of securing sensitive data. The demand for stronger data protection mechanisms has driven growth in this sector.
Major Vendors in the Global Peptide Synthesis Service Market:
- Bachem
- ScinoPharm
- Xinbang
- PolyPeptide
- Thermofischer
- GL Biochem
- AnaSpec
- USVPeptides
- Hybio
- Genscript
- LifeTein
- New England Peptide
- Proimmune
- 21st Century Bio
- CPC Scientific
- Biomatik
- JPT
Request for Discount @ https://www.marketdigits.com/request/discount/3709
Increasing Demand for Therapeutic Peptides
The peptide synthesis service market is experiencing a significant boost driven by the increasing demand for therapeutic peptides in the pharmaceutical and biotechnology industries. Therapeutic peptides, composed of short sequences of amino acids, have gained prominence as potential treatments for a diverse range of diseases, including cancer, diabetes, and cardiovascular disorders. This surge in demand is primarily attributed to the unique properties of peptides, such as their high specificity, low toxicity, and the ability to mimic natural physiological processes. One key factor fueling this demand is the ongoing shift in drug development towards biologics and precision medicine. Therapeutic peptides, being a class of biologics, offer advantages in terms of target specificity and reduced side effects compared to traditional small-molecule drugs. As researchers and pharmaceutical companies delve deeper into understanding the molecular basis of diseases, the potential therapeutic applications of peptides continue to expand. This has led to an increased focus on custom peptide synthesis services to meet the specific requirements of drug development projects.
Market Dynamics
Drivers:
- Increasing Demand for Therapeutic Peptides
- Growing Interest in Personalized Medicine
Opportunities:
- Rising R&D Activities in Biotechnology and Life Sciences
- Technological Integration and Automation:
Rising R&D Activities in Biotechnology and Life Sciences
The Peptide Synthesis Service Market is poised for significant opportunities, propelled by the rising research and development (R&D) activities in the biotechnology and life sciences sectors. As these industries continue to expand their exploration of novel therapeutic agents, diagnostics, and functional biomolecules, the demand for custom peptide synthesis services is experiencing a notable upswing. The intricate role of peptides in various biological processes and their potential applications in drug development, diagnostics, and beyond make them a focal point for biotechnological and life sciences research. One of the key drivers of the heightened demand for peptide synthesis services is the increasing complexity of R&D endeavors. Biotechnology and life sciences companies are engaged in ambitious projects aimed at uncovering the molecular mechanisms underlying diseases and developing targeted interventions. Peptides, with their ability to modulate specific biological pathways and interactions, have become essential tools in this quest for deeper insights and innovative solutions. Consequently, there is a growing need for custom peptides tailored to the unique requirements of diverse research projects.
The market for Peptide Synthesis Service is dominated by North America.
The peptide synthesis service market is prominently led by North America, establishing the region as a key player in the global landscape of peptide synthesis services. The dominance can be attributed to the robust presence of pharmaceutical and biotechnology companies in North America, which exhibit a high demand for custom peptides in various applications. The region’s advanced infrastructure, substantial investments in research and development, and a well-established regulatory framework contribute to its leadership in the peptide synthesis service market. Moreover, the relentless pursuit of innovation in drug discovery and therapeutic applications by North American pharmaceutical giants enhances the need for specialized peptide synthesis services. The strategic collaboration between academic research institutions and industry players further propels North America’s position in the market, fostering a conducive environment for advancements in peptide synthesis technologies. The continent’s proactive approach to adopting cutting-edge scientific methods and technologies positions it at the forefront of peptide synthesis services. As a result, North America not only meets its domestic demand for custom peptides but also plays a pivotal role in influencing the global peptide synthesis service market, shaping the future of therapeutic development and molecular research in the pharmaceutical and biotechnology sectors.
The Pharmaceuticals & Biotechnology Segment is Anticipated to Hold the Largest Market Share During the Forecast Period
Based on end-user the peptide synthesis service market is segmented into pharmaceuticals & biotechnology companies, CDMOs & CROs, and academics & research institutes. Pharmaceuticals and biotechnology companies stand as the predominant end users in the peptide synthesis service sector. Their dominance stems from the increasing demand for custom peptides in drug development, diagnostics, and therapeutic applications. As key players in the life sciences industry, these companies leverage peptide synthesis services to create tailored peptides for research purposes, drug discovery, and production of biopharmaceuticals. The intricate role of peptides in advancing molecular medicine aligns with the research and development objectives of pharmaceuticals and biotechnology firms, establishing them as primary drivers and consumers within the rapidly evolving landscape of peptide synthesis services.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3709
Browse Similar Reports:
DNA Synthesis Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Gene Synthesis Market 2030 By Type, Distribution Channel, End-user and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Peptide Therapeutics Market 2023 – 2030 Type Of Manufacturer, Route Of Administration, Synthesis Technology, Application, Type (Generic, Innovative),- Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. SingaporeOutlook.com takes no editorial responsibility for the same.
